• Axumin PET/CT Scans Lead to Treatment Changes in Most Recurring Prostate Cancer Patients, Phase 3 Trial Shows
  • MDxHealth Announces Global Rights to Market Philips’ Prostate Cancer Prognostic Test
  • Blood Tests May Identify Patients Less Likely to Benefit from Hormone Therapies
  • Zytiga Rejected in England as First-line Treatment for Newly Diagnosed Advanced Prostate Cancer
  • Sotio Starts Phase 1/2 Trial of DCVAC/PCa plus ONCOS-102 in Advanced Prostate Cancer
  • IsoPSA Blood Test Shows Promising Results for Early Prostate Cancer Diagnosis
  • Keytruda Provides Disease Control in Patients with Metastatic Castration-resistant Prostate Cancer, Trial Shows
  • Laser-guided Treatment Better in Long Term than Monitoring for Low-risk Prostate Cancer, New Phase 3 Data Show
  • Yonsa, New Formulation of Abiraterone Acetate, Approved for Advanced Castration-resistant Prostate Cancer
  • CellCentric Raises $26M to Advance Prostate Cancer Therapy Candidate CCS1477
  • ‘Cancer Trap’ May Improve Early Diagnosis, Treatment of Prostate, Other Cancers
  • Obesity Can Improve Overall Survival in Late-stage Prostate Cancer Patients But Not Disease Outcomes, Study Finds